4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-064437
Chief Financial Officer sold 36,923 shares at $1.32 ($48,628)
- Chief Financial Officer acquired 36,923 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moran Sean F. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-16 | Exercise or conversion : show line 1 in the form | +36,923 | $0.17 | $6,118 | 386,533 | D |
| 2020-12-16 | Sale : show line 2 in the form | −36,923 | $1.32 | $48,628 | 349,610 | D |
| Open-market sales · 36,923 sh · avg $1.32 · $48,628 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2020-12-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −36,923 | $0.17 | $6,118 | $0.17 | 2024-01-28 | 36,923 | 36,923 | D |
Loading xslF345X03/doc4.xml…